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Abstract
RASSF enzymes act as key apoptosis activators and tumor suppressors, being downregu-
lated in many human cancers, although their exact regulatory roles remain unknown. A key
downstream event in the RASSF pathway is the regulation of MST kinases, which are main
effectors of RASSF-induced apoptosis. The regulation of MST1/2 includes both homo- and
heterodimerization, mediated by helical SARAH domains, though the underlying molecular
interaction mechanism is unclear. Here, we study the interactions between RASSF1A,
RASSF5, and MST2 SARAH domains by using both atomistic molecular simulation tech-
niques and experiments. We construct and study models of MST2 homodimers and MST2-
RASSF SARAH heterodimers, and we identify the factors that control their high molecular
stability. In addition, we also analyze both computationally and experimentally the interac-
tions of MST2 SARAH domains with a series of synthetic peptides particularly designed to
bind to it, and hope that our approach can be used to address some of the challenging prob-
lems in designing new anti-cancer drugs.
Author Summary
We model the conformational changes and protein-protein interactions of enzymes
involved in signaling along the Hippo pathway—a key molecularmechanism that controls
the process of programmed cell death in eukaryotic cells, including cells affected by cancer.
Combiningmodern computational modeling techniques with experimental information
from X-ray crystallography and systems biology studies, can unveil detailedmolecular
interactions and lead to novel drugs. Here, we study the atomistic mechanisms and inter-
actions betweenMST2 and RASSF-type kinases, through their respective SARAH
domains—highly conserved, long, terminal α-helices, which play essential roles in the acti-
vation of MST kinases and, therefore, in modulating apoptosis. In spite of their key roles
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in mediating cell signaling pathways, there is little structural information available for the
RASSF SARAH domains and their dimerization with the MST2 SARAH domains. In par-
ticular, the RASSF1A crystal structure is not available yet. Here, we model, refine and vali-
date atomistic structuralmodels of dimers of the RASSF1A and MST2 SARAH domains,
studying the interaction and the dynamic behavior of these molecular complexes using
homologymodeling, docking and full atomistic molecular dynamics simulations. Experi-
mentally, we validate our approach by designing a novel peptide that can disrupt effec-
tively MST2 homo and hetero SARAH dimers.
Introduction
There is an acute need for novel drug targets and strategies in the fight against cancer. New
directions could emerge from exploring the tumor-suppressive RASSF signaling pathway and
its downstream effectors, the MST1/2 kinases, which control tissue homeostasis by balancing
cell proliferation and cell death through apoptosis [1–4]. The activation of MST1/2 kinase
activity is regulated by either homo-dimerization or by interactions with scaffold proteins such
as WW45 and different members of the RASSF family. The regulation of MST1/2 by RASSF
scaffolds is a key event in this pathway, but remains poorly understood [3, 5]. The evidencewe
have so far indicates that the RASSF family members RASSF1A and RASSF5 (also known as
NORE1 or RALP) are tumor suppressors that mediate apoptosis through different effectors
includingMST1/2 kinases, but their exact regulation by RASSF proteins is incompletely under-
stood [6]. RASSF1A and RASSF5 regulate MST1/2 kinase activity by direct protein-protein
interaction through their respective SARAH domains [7]. The SARAH domain is a long, con-
servedα-helix at the C-terminal end, known to be a key protein-protein interaction domain
[8]. A comparative analysis of the RASSF family SARAH domains has been previously pub-
lished by Chan et al. [9] and discussed also in Ref. [6]. We showed that other proteins that do
not have a SARAH domain themselves, such as RAF1, could nevertheless also regulate MST1/2
kinase activity through direct binding to their SARAH domain [1, 10], confirming the impor-
tance of protein-protein interactions via the SARAH domain in the regulation of these kinases.
In addition, RASSF proteins were shown to be able to activate or inhibit MST1/2 kinase activity
upon heterodimerization [5].
Given the importance that dimerization of MST1/2 and the RASSF proteins have on the reg-
ulation of MST1/2-dependent apoptosis, several studies have focused on the description of the
interaction betweenRASSF5 and MST proteins through their SARAH domains, as summa-
rized recently in Ref. [6]. Accordingly, crystal structures are available for the MST-RASSF5
SARAH domain dimers [11, 12]. The MST2-RASSF5 SARAH domain hetero-dimer (Fig 1)
crystal structure was recently determined [11, 13], and further analysis of the MST2-RASSF5
interactions from the crystal structure was carried out from an experimental point of view [11].
However, only few studies considered the structure of the RASSF1A SARAH domain and its
dimerization with the MST2 SARAH domain [14]. Importantly, the RASSF1A loss of expres-
sion is arguably one of the most frequent events in human solid tumors, and the characteriza-
tion of RASSF1A-MST2 heterodimers could help to understand the important role of
RASSF1A as a tumor suppressor [6].
In this study, we analyze the specific dimeric interactions between the helical SARAH
domains of MST2 and RASSF enzymes. As indicated above, SARAH domains have been previ-
ously characterized in experimental in vivo studies of MST2, for example by using protein
arrays to demonstrate their specific binding [1, 4]. However, this paper is our first modeling
SARAH Domain-Mediated MST2-RASSF Dimeric Interactions
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study that thoroughly examines the interactions between SARAH domains and SARAH—
RASSFx interactions. Based on recently solved crystal structures of MST2-RASSF5 SARAH
heterodimers, we use a combination of homologymodeling, docking,molecularmodeling and
atomistic molecular dynamics (MD) methods, to construct and study a variety of models of
MST2-MST2 homodimers, as well as of MST2-RASSF5 and MST2-RASSF1A SARAH hetero-
dimers, and we identify the factors that control their high molecular stability. We also study
the interaction of theMST2 SARAH domain with a de novo designed peptide, and demonstrate
both via in silicomodeling and experimentally that this peptide disrupts the MST2-RASSF1A
interactions, as predicted. A summary, schematic representation of the principal monomeric
and dimeric systems modeled in this study is illustrated in Fig 1A.
Results
Sequence analysis of RASSF SARAH domains
Fig 1B illustrates the MST2-RASSF5 complex from the only available crystal structure (PDB
ID: 4LGD) [13] showing the direct interaction between the RASSF5 SARAH domain (red) and
the MST2 SARAH domain (blue). The MST2 kinase domain (blue) is also resolved in the
4LGD crystal structure. To model the structure of RASSF1A SARAH domains, we performed
multiple sequence analysis to infer similarities with structurally resolved homologues (e.g.,
RASSF5) from the same family. We performed a detailed sequence comparison of RASSF1-to-
6 SARAH domains, using multiple sequence alignment obtained with the Clustal Omega soft-
ware [15–17], which allowed us to infer its similarity with structurally resolved homologues
(e.g., RASSF5) from the same family.
Our analysis showed clearly that the RASSF SARAH domains contain multiple conserved
sites (Fig 2A). Importantly, the pairwise alignment betweenRASSF1A and RASSF5 (Fig 2B)
showed that their respective SARAH domains have 54.1% sequence identity and 89.4%
Fig 1. Dimeric interactions of SARAH domains. (A) Schematic representation of the principal monomeric and dimeric systems modeled in this study.
Arrows represent the steps followed to construct our molecular models. (B) MST2-RASSF5 complex from crystal structure (PDB ID: 4LGD) showing the
direct interaction between RASSF5 (red) and MST2 (blue) SARAH domains. The MST2 kinase domain (blue) is also resolved in the 4LGD crystal
structure (the linker segment between the catalytic and SARAH domains is not resolved).
doi:10.1371/journal.pcbi.1005051.g001
SARAH Domain-Mediated MST2-RASSF Dimeric Interactions
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sequence similarity. These values are significantly large (i.e., larger than in other recent studies
using homologymodeling in conjunction with MD simulations [18]), and this observation is
both a strong motivation and a justification for using the crystal structure of the RASSF5
SARAH domain as a template for the homologymodeling of the RASSF1A SARAH domain
structure [6].
MST2 SARAH domain as docking target
We continued our study by generating an atomistic model of the structure for the RASSF1A
monomer built by homologymodeling, using the RASSF5 crystal structure (4LGD: Chain G)
as a template (Fig 1). Subsequently, the RASSF1A SARAH structure was docked onto the
MST2 SARAH domain. A large number (approx. 2000) of possible dimer structures were gen-
erated using the Zdock program [19–21] (Fig 3). We note that coarse-grainedmodeling
approaches, including docking, have been very successful in other recent computational
Fig 2. Sequence analysis. Sequence alignments obtained using Clustal Omega for SARAH domains of (A)
MST2 and RASSF1A (31.4% sequence identity and 64.6% similarity), (B) RASSF1A and RASSF5 (54.1%
sequence identity and 89.4% similarity), (C) RASSFn (with n 2 [1,6]), and (D) MST2, RASSF1A, and
RASSF5, as indicated, and the new peptide with its designed (marked “peptide”) and “scrambled”
sequences. The colors correspond to: red = hydrophobic residue (small + hydrophobic (incl. aromatic—Y));
blue = acidic residue; green = hydroxyl + sulfhydryl + amine + G; magenta = basic residue—H. The asterisk
(*) indicates a single, fully conserved residue. In the bottom row, the alignment results are represented as
follows: a colon (:) indicates conservation between groups of strongly similar properties (i.e., scoring > 0.5 in
the Gonnet PAM 250 matrix), and a period (.) indicates conservation between groups with weakly similar
properties (i.e., scoring = < 0.5 in the Gonnet PAM 250 matrix).
doi:10.1371/journal.pcbi.1005051.g002
SARAH Domain-Mediated MST2-RASSF Dimeric Interactions
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approaches for studies of protein-protein interactions [22–25]. The Zdock scoring function
values for MST2-MST2 (blue), MST2-RASSF5 (red), and MST2-RASSF1A (green) dimers
were shown to be effective in identifying only a fewmost favorable binding modes, indicating
that our strategy was valid for this study. Importantly, our analysis assigned high Zdock scores
for cases when crystal structures are available (Fig 3 red, yellow and purple arrows), further val-
idating our approach. Thus, we decided to use the docking-generated structures with the high-
est scoring function as initial models to study the MST2-RASSF1A dimer in the subsequent
atomistic molecular dynamics study. However, we note that other recent docking approaches,
including additional factors such as side chain flexibility, may further improve structuralmod-
els before being refined with atomistic MD approaches [23, 24].
Interestingly, the MST2-RASSF1A structure with the highest scoring function corresponded
to that in which both protomers are aligned in an anti-parallel topology, similar to those found
in the crystal structure of MST2-RASSF5 [11, 13].
In addition to the analysis of the dimerization of different SARAH domains we also analyzed
the structure of the interaction between the SARAH domain and a peptide that has been shown
experimentally to bind to the MST2 SARAHdomain [4]. In this case, similarly to
MST2-RASSF1A, our docking study identifies only one structure standing out from the rest
with the highest scoring function (Fig 3). Moreover, the top scoring 100 docking structures (out
of a total set of 2000) appear to be clustered near the very same interface area, and no additional
high-scoring contact area betweenMST2 and the designed peptide was found using Zdock.
All-atom MD simulations of MST2 SARAH dimer structures
To validate and refine the results of our Zdock study we studied homo- and heterodimers of
MST2-MST2, MST2-RASSF5 and MST2-RASSF1A using atomistic molecular dynamics (MD)
with explicit water molecules.
A summary of the simulation types performed and analyzed here is given in Table 1.
Fig 4 shows the three dimers in our MD study:MST2-RASSF5 from crystal structure
(4LGD), MST2-MST2, and MST2-RASSF1A. The structure of the MST2-MST2 homodimer
Fig 3. Molecular docking. Histogram of Zdock scores for MST2-MST2 (blue), MST2-RASSF5 (red),
MST2-RASSF1A (green), and MST2-Peptide (black) dimers. Numbers indicate structures with similar
scores. Arrows indicate Zdock scores obtained for crystal structures, when available, (i.e., red, yellow and
purple), and also the highest scoring dimer structures used for subsequent MD refinement (i.e., blue & green,
for cases where crystal structures are not available).
doi:10.1371/journal.pcbi.1005051.g003
SARAH Domain-Mediated MST2-RASSF Dimeric Interactions
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modeled corresponds to a parallel alignment of both protomers (Fig 4A). The crystal structure
of the MST2-RASSF5 dimer was refined with MD (Fig 4B). The structure of the
MST2-RASSF1A dimer selectedwas the one with the highest scoring function, which addition-
ally presented a parallel alignment of both SARAH domains (Fig 4C).
Cα root-mean-square deviation (RMSD) values for all four atomistic systems, both homo-
and hetero-dimers, are shown in Fig S1 in S1 File. We observed that the RMSD values in both
systems are converged and remain stable along our entire trajectories. Additionally, solvent
accessible surface area (SASA) was estimated in order to assess the solvation properties of het-
ero-dimers. Fig S1 in S1 File shows that in all cases, SASA values also converged, remaining
almost constant and not showing any significant changes along the trajectories. Thus, the
Table 1. MD simulation parameters of the 12 atomistic systems of SARAH domain dimers (MST2-MST2, MST2-RASSF5, MST2-RASSF1A, and
MST2-PEP, MST2-SCR, RASSF1A-PEP and RASSF1A-SCR) solvated using explicit TIP3P water molecules.
No. Systems Simulation time (ns) No. of residues Water molecules Total no. of atoms Initial dimensions (Å)
Dimers
1. MST2-RASSF5 200 94 14,912 46,408 79x78x80
2. MST2-RASSF1A 200 94 14,251 44,407 78x78x78
3. MST2-MST2 200 94 22,543 69,298 90x90x90
4. MST2-RASSF5 400K 160 94 14,912 46,408 79x78x80
5. MST2-RASSF5 450K 70 94 14,912 46,408 79x78x80
6. MST2-RASSF5 500K 55 94 14,912 46,408 79x78x80
7. MST2-PEPS 200 64 13,205 40,729 75x75x76
8. MST2-PEPL 200 70 12,775 39,620 75x75x75
9. MST2-PEPA 200 70 14,684 45,357 78x78x78
10. MST2-SCR 200 70 12,771 39,612 75x75x75
11. RASSF1-PEP 200 69 13,914 43,029 77x77x77
12. RASSF1-SCR 200 69 13,572 43,003 76x76x77
doi:10.1371/journal.pcbi.1005051.t001
Fig 4. Structures of SARAH homo- and heterodimers. Top: Structures of (A) MST2-MST2 (purple-
purple), (B) MST2-RASSF5 (purple-cyan) and (C) MST2-RASSF1A (purple-green) dimers. The
MST2-RASSF5 dimer corresponds to the 4LGD crystal structure, and the other two correspond to our
homology models. Bottom: Lateral views of the same structures from above. On the r.h.s., each structure
was colored according to its residue-level RMSF value calculated using MD trajectories.
doi:10.1371/journal.pcbi.1005051.g004
SARAH Domain-Mediated MST2-RASSF Dimeric Interactions
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buried surface at the interface between protomers upon dimer formation is almost constant
along the trajectory.
Root-mean-square fluctuation (RMSF) values for all four dimer types were calculated in
order to gain insight in the flexibility of the SARAH domains upon complex formation (Fig 4,
lower panel r.h.s.). In general, all the residues fluctuate very little with respect to the initial
structure (RMSF depicted as blue), with the exception of the C-terminal loop (white-red)
which presents more flexibility. In the case of the MST2-MST2 dimer, the residues located in
the centers of the helices presented more mobility as compared with the corresponding resi-
dues in the RASSF1-6 dimers.
We carried out additional MD simulation at different temperatures over the MST2-RASSF5
crystal structure dimer, at 400 K, 450 K and 500 K. Those trajectories showed that even at 400
K, MST2-RASSF5 dimer was stable at least during 160 ns (see Fig S2 in S1 File), while in the
450 K and 500 K, both SARAH domains became unstable after 30–50 ns.
We also calculated the interaction energy between protomers within the dimers for all the
systems studied. The total interaction energy (see Fig S3A in S1 File, black line) was defined to
include electrostatic (green) and van derWaals (vdW, blue) interactions. This analysis showed
that the dominant term is electrostatic (Fig S3A in S1 File). The vdW term remains constant
along the trajectory in all the cases, and it has a relatively minor contribution. The electrostatic
interaction term accounts for -527.5 ± 69.6, -483.4 ± 77.1, -426.9 ± 71.5 kcal/mol for
MST2-MST2, MST2-RASSF5, and MST2-RASSF1A dimers respectively, while the vdW term
accounts for only -149.1 ± 7.1, 118.4 ± 7.6, 114.6 ± 7.2 kcal/mol.
These results based on MD simulations also show that the total interaction energy of the
MST2-MST2 dimer is only marginally more stable than the MST2-RASSF5 and
MST2-RASSF1A dimers (Fig S3 in S1 File). The average total interaction energy for
MST2-MST2 is -676.5 ± 67.8 kcal/mol, while in the case of MST2-RASSF5 and
MST2-RASSF1A, it accounts for -601.7 ± 75.0 and -541.5 ± 70.4 kcal/mol, respectively. Addi-
tionally, the total interaction energy distributions, calculated for each dimer along its trajectory
(Fig S3B in S1 File), show that all three dimers present similar populations within the same
range of energies.
To further probe the interaction preferences between the SARAH domains of MST2 and
RASF1A and RASSF5, we have also used six different contact potentials to estimate the nor-
malized contact energies based on structures obtained fromMD trajectories in each case.
While contact potentials offer only rough approximations for the relative stability of molecular
structures, have been remarkably successful in other studies of protein-protein interactions
[22, 24]. In Fig S11 in S1 File we illustrate a comparison of histograms of residue-residue con-
tact potential values from 20 x 20 contact potential matrices [26] developed by Hinds and
Levitt (HL [27]), Betancourt and Thirumalai (BT [28]), Miyazawa and Jernigan (MJ-99 [29]),
Skolnick et al. (SJKG [30], and SKO from Ref. [31]), and Tobi et al.[32] (TSLE from Ref. [32]).
These normalized contact potentials are further used in Fig S12 in S1 File to calculate relative
contact potentials values for structures of MST2-RASSF1 (notation MR1 on the horizontal
axis), MST2-MST2 (MM) and MST2-RASSF5 (MR5) dimers. The calculations were performed
for the six popular contact potentials represented Fig S11 in S1 File for three cases: (A) dimer
structures before MD, (B) the dimer structures from our MD simulations corresponding to
frames with the smallest RMSD values compared to the average over the respective trajectory
(RMSDave), and (C) the dimer structures from the sameMD trajectories but corresponding to
frames with the largest RMSDave (to illustrate that even in this case the relative values for MR1
are still smaller than for MM andMR5 dimers). In Fig S12 in S1 File, a residue-residue contact
cut-off distance of 5.5 Å between side-chain atoms was used, though we obtained similar
results when using cut-off distances of 5.0 Å and 6.0 Å on the same structures.
SARAH Domain-Mediated MST2-RASSF Dimeric Interactions
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Interestingly, as shown in Fig S12 in S1 File, there is a remarkable agreement between results
obtained for the six different contact potentials used here, in spite of their diversity and well-
known approximate accuracy due to their intrinsic coarse-grained character. Nevertheless, in
agreement with the atomistic MD energies, the results suggest that all three dimer types have
similar stabilities, though this timeMST2-RASSF1A dimers appear to be marginally more sta-
ble. This is in agreement with experimental observations that both RASSF1A and RASSF5
SARAH domains could disturb competitively MST2 SARAH homodimers.
As an additional probe of the relative stability of the various dimeric systems for which we
have MD simulations available, we have also calculated potential of mean force (PMF) profiles
as presented in Figs S14 and S15 in S1 File. In Fig S14 in S1 File, results are presented for the
MST2-MST2, MST2-RASSF1 and MST2-RASSF5 systems calculated from the corresponding
dimer all-atomMD simulations using the recent dynamic histogram analysis method (DHAM)
method [33]. The profiles were calculated for the distance between carbon alpha (CA) atoms of
the two monomers that has the smallest average value along the correspondingMD trajectory.
To probe convergence, in Fig S14 in S1 File the PMF profiles are presented for (A) the full trajec-
tory, (B) the first third of the data, (C) the second third, and (D) the final third of the data. The
first 20 ns (i.e., ~10%) of data from each trajectorywere not included in this analysis. Though
free energy calculations for interactions between large molecular complexes are notoriously dif-
ficult, the calculated PMF profiles suggest that the RASSF1 SARAH domains could bind better
to monomericMST2 SARAHdomains thanMST2 itself (e.g., the MST2-RASSF1 PMF values in
Fig S14 in S1 File, red curves, appear to have narrower profiles when compared to MST2-MST2,
blue curves, though this effect is weaker in theMST2-RASSF5 case, yellow curves).
Similarly, PMF profiles for the MST2-PEPA, MST2-PEPL, MST2-PEPs, MST2-SCR,
RASSF1-PEP, and RASSF1-SCR systems calculated from the corresponding dimer all-atom
MD simulations using the DHAM method are also presented in Fig S15 in S1 File [33]. Here,
the PMF profiles illustrate clearly the trends discussed in detail above (e.g., most notably that
scrambled peptides have a lower dissociation barrier than their corresponding counterparts).
In order to provide further information on the MST2-MST2 homodimer, we have carried
out a docking study (see yellow plot in the histogram in Fig 3) of the MST2-MST2 dimer using
the crystal structure available (4HO9). We have evaluated the structural differences between
the 4HO9 structure and the results from docking using 4HO9 as template. Our results (see in
Fig S13 in S1 File upper panel) indicate that the differences between both docked and crystal
structures are remarkably small, corresponding to alpha carbon (CA) RMSD of 2.208Å. Fur-
thermore, we have repeated the experiment, comparing the dimer obtained from docking
using 4LGD (MST2 monomer) and the available 4HO9 crystal structure (see in Fig S13 in S1
File lower panel). Once more, the docking results are in very high agreement with the crystal
structure, with a CA RMSD of 2.096 Å.
In order to gain additional insight of the different interactions that occur upon complexa-
tion between the protomers, salt bridges and hydrogen bonds were analyzed. A deeper analysis
of the MD structures revealed several salt bridges present in these dimers (see Fig 5 and
Table 2).
The MST2-MST2 dimer presents symmetrical interactions betweenK441-D479,
D456-R474 and E462-R469, with the last two pairs being dominant in terms of shorter distance
along the trajectory (see Fig S4 in S1 File). This is because the first salt bridge (K441-D479)
belongs to the terminal ends of both helixes and it is very flexible, making this salt bridge less
stable. The MST2-RASSF5 dimer contains a large number of salt bridges, and a total of 12
interactions were found, while in MST2-RASSF1A dimer 9 salt bridges were located. In the
MST2-MST2 dimer the electrostatic interactions are mainly between the two pairs R469-E463
(Pc = 0.745) and R474-D465 (Pc = 0.906), where Pc is the probability of formation of the
SARAH Domain-Mediated MST2-RASSF Dimeric Interactions
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corresponding contact as estimated from our MD trajectories. In the case of MST2-RASSF5,
more salt bridges come into play accounting for the highest contact propensity along the MD
simulation: R467-E388 (Pc = 0.877), K473-E366 (Pc = 0.154), R474-E385 (Pc = 0.289) which
are competing with the formation of R474-E388 (Pc = 0.800) and E463-K398 (Pc = 0.751). Fur-
thermore, the MST2-RASSF1A dimer showed similar interactions with the MST2-RASSF5
dimer, R467-E316 (Pc = 0.911) and R474-E316 (Pc = 0.819), but also some similarities with the
MST2 homodimer, D465-R331 (Pc = 0.981) and E462-K326 (Pc = 0.609). In view of these
results, we concluded that R474 (MST2) and E462 play an important role in all these dimers,
based on the Pc values observed for those amino acids. R467 and D456 are also highlighted as
main “anchoring” contacts between dimers, especially betweenRASSF1-6 and MST2.
Our structural analysis identified the charged residues and salt bridges involved in the for-
mation of the three models (Fig 5): (A) MST2-MST2 (blue-blue), (B) MST2-RASSF5 (blue-
Fig 5. Charged residues and salt bridges in SARAH dimers. Representation of charged residues and
salt bridges present within the three SARAH dimer types: (A) MST2-MST2, (B) MST2-RASSF5, and (C)
MST2-RASSF1A. Green dashed lines correspond to salt bridges.
doi:10.1371/journal.pcbi.1005051.g005
Table 2. Salt bridge dynamics in SARAH domain dimers (MST2-MST2, MST2-RASSF5 and
MST2-RASSF1A). Salt bridge contacts formed in more than 10% of the trajectory are highlighted as bold.
MST2 MST2 RASSF5 RASSF1A
K 441 D479 (0.55%) E412 (41.7%) E366 (0.1%)
R 451
R 467 E385 (1.3%) E316 (91.1%)
E388 (87.7%) E317 (0.6%)
R 469 E462 (74.5%) E366 (0.5%)
K 473 E366 (15.4%) E315 (1.3%)
E387 (1.7%)
R 474 D 456 (90.6%) E385 (28.9%) E316 (81.9%)
E388 (80.0%)
K 484 D370 <0.1% D298 (0.3%)
D 438 K405 (1.8%) K333 (3.5%)
D 456 R474 (90.6%) R403 (0.5%) R331 (98.1%)
E 462 R469 (74.5%) K398 (75.1%) K326 (60.9%)
E 465
D 479 K441 (0.55%)
doi:10.1371/journal.pcbi.1005051.t002
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red), (C) MST2-RASSF1A (blue-green). As observed, electrostatic interactions play a primary
role in controlling the assembly and stability of MST2 homo- and heterodimers. Notably, in
MST2-RASSF5 and MST2-RASSF1A interactions the two antiparallel helices present a signifi-
cant charge complementarity between their N-terminal and C-terminal regions. The time-
dependent dynamics of several representative salt bridges is illustrated in the Fig S4 in S1 File.
Recent studies have pointed out that hydrophobic isoleucine-leucine (ILE-LEU) pair inter-
actions mediating packing betweenα-helixes also can contribute to the stabilization of such
dimers [34]. Therefore, we analyzed the ILE-LEU pairs within the dimers, and several were
found in MST2-MST2 and MST2-RASSF dimers (Fig 6). The number of those pairs and the
particularly strategic location at the N-terminal, C-terminal and in the center of the dimer sug-
gest a large stabilization. Thus, we conclude that these ILE-LEU pair interactions together with
the salt bridges are the main elements responsible for dimer stability and, possibly, formation
in the MST2-RASSF1-6 and MST2-MST2 SARAH domains.
In addition to the salt bridges discussed above, several hydrogen bonds (HBs) were identified
between protomers, which also contribute to the stability of dimers. The total number of hydro-
gen bonds (NHB, calculated using VMD [35]), that occur along the MD simulation within the
dimers, is 16, 31 and 24 for MST2-MST2, MST2-RASSF5 and MST2-RASSF1A. Table 3 shows
the total occupancy of those HBs along the wholeMD trajectory, including the donor and
acceptor motif. Furthermore, the time-dependent dynamics of the hydrogen bonds is depicted
also in Fig S5 in S1 File. We observed that MST2 key hydrogen donors correspond to Y470 and
R474 amino acids that are involved in HB within all the dimers studied here. Othermain impor-
tant contributions arise from the residue R467, which presents hydrogen bonds with Q389
(12.5%) and E388 (52.0%) in RASSF5, and with E316 (48.3%) of RASSF1A, and from the resi-
due R469 that presents hydrogen bonds with E462 (98.7%) in MST2-MST2 dimer.
Additionally, we calculated the hydrophobic (SASAH) and hydrophilic (SASAP) fractions of
the solvent accessible surface area (SASA) for the representative structure of each system in
order to gain insight on the hydrophobic interactions (see Fig S6 in S1 File). From this calcula-
tion, it was not clear whether hydrophilic (pink) or hydrophobic (green) exposed areas are pre-
dominant. To clarify this point we quantified the total exposed area in these dimers, together
with the SASAP and SASAH values of the representative structures using the GetArea program
Fig 6. Hydrophobic interactions in SARAH dimers. Representation of Ile (yellow)–Leu (purple) contacts
present within the three dimer types (A) MST2-MST2, (B) MST2-RASSF5 and (C) MST2-RASSF1A.
doi:10.1371/journal.pcbi.1005051.g006
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[36]. These values, given in Table 4, show that the MST2-MST2 dimer has the largest exposed
hydrophobic surface, whileMST2-RASSF5 presents the smallest one.
Disruptor peptide interacting with MST2 and RASSF1A SARAH
domains
In previous work, the interaction betweenRAF1 and MST2 protein was studied from experi-
mental and computational point of view showing that MST2 coordinates crosstalk between the
mitogenic Raf and pro-apoptotic MST2 pathway [4]. This study showed that a 17-mer peptide
designed based on the binding site of RAF1 to the MST2 SARAH domain was able to disrupt
RAF1-MST2 dimerization. Understanding how such peptides bind and disrupt the dimeriza-
tion process is key for future development of anti-cancer drugs that can activate MST2 by
releasing it from the inhibitory interaction with RAF1. In addition, it will help to design
Table 3. Hydrogen bond (HB) dynamics in SARAH domain dimers (MST2-MST2, MST2-RASSF5 and MST2-RASSF1A). Only HBs with more than
1% occupancy are shown. HBs formed in more than 10% of the trajectory are highlighted in bold. Top: MST2 domains acting as an HB donor, Bottom: MST2
acting as a HB acceptor.
MST2 (HB Donor) MST2 RASSF5 RASSF1A
K441 E412 (21.2%)
E408 (4.0%)
E446
Q449
R467 Q389 (12.5%) E316 (48.3%)
E388 (52.0%)
R469 E462 (98.7%) E366 (3.0%) E294 (4.0%)
Y470 E462 (59.6%) E387(24.2%) H319 (23.6%)
E315 (9.2%)
K473 E366 (7.0%) E294 (1.1%)
R474 D456 (47.4%) E388 (45.4%) E316 (54.8%)
E385 (9.8%) Q313 (11.1%)
K484 L443 (6.0%) F372 (3.0%) D298 (18.9%)
K441 (4.8%) D370 (9.4%) F300 (3.3%)
MST2 (HB Acceptor)
K441 K484 (5.2%) S413 (1.3%)
L443 K484 (4.5%) S413 (17.1%)
D438 K333 (1.2%)
Q449
D456 R474 (25.4%) R403 (1.6%) R331 (62.1%)
E462 R469 (88.6%) Y399 (58.7) K326 (28.8%)
Y470 (56.0%) K398 (38.6) Y327 (51.2%)
E465
Y470 K391 (1.8%)
P476 W369 (2.3%)
doi:10.1371/journal.pcbi.1005051.t003
Table 4. Hydrophobic (SASAH) and hydrophilic (SASAH) solvent accessible surface area (SASA), in Å2, for each of the three types of dimers.
SASAH SASAP Total SASA % Hydrophobicity
MST2-MST2 4391.6 2864.7 7256.3 60.5%
MST2-RASSF5 4170.8 2990.4 7161.3 58.2%
MST2-RASSF1A 4426.2 2940.1 7366.2 60.1%
doi:10.1371/journal.pcbi.1005051.t004
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peptides that either improve or do not affect RASSF1A or MST2 interactions, as desired, or
could also simultaneously disrupt RASSF1 and MST2 dimerization. For that reason, we carried
out a computational study of the possible interactions between the so-called disruptor peptide
and the MST2 and RASSF1A SARAH domains. In order to perform this study, we used homol-
ogymodeling and docking studies to obtain the initial structures and, in a subsequent step, full
atomistic MD simulations to validate and analyze these interactions.
Four different systems were tested. We first used the disruptor peptide (PEPS) with the
sequence “RYTAKRQPILDAMDAK” corresponding to the minimal sequence of MST2
known to interact with RAF1 [1]. A longer peptide (PEPL) “IEELRQRYTAKRQPILDAM-
DAK”, including flanking sequences of MST2-RAF1 interaction domain, was also tested in
order to see the influence of the length of the peptide on the interaction. Both initial dimeric
structures (MST2-PEPS and MST2-PEPL) were obtained from the highest scoring structure in
the docking study. In addition, PEPL was aligned to the originalMST2-MST2 SARAH domains
(PEPA). Finally, we also studied a control peptide, where the PEPL sequence was scrambled,
“TDKRALDQLRMQEIKARYPFQA”. As the RAF1 binding domain overlaps with the
RASSF1A binding in the MST2 SARAH domain we also investigated the structures of RASS-
F1A-PEPA and RASSF1A-SCR dimers (see Fig S9 in S1 File for sample structures of RASS-
F1A-SCR dimers along the 200 ns MD trajectory).
Fig S7 in S1 File shows the RMSD of the four MST2-Peptide systems studied.When we
compared the interactions between PEPS and PEPL and the MST2 SARAH domain we
observed that in the latter, the dimer was more stable than in the former. In fact, the fluctuation
of PEPS around the MST2 SARAH domain is larger than PEPL. Once the peptide is aligned
(PEPA) with the MST2 SARAH domain in the MST2-MST2 SARAH domain dimer, the pep-
tide remains almost constant and no significant deviation from the initial structure can be
found after 200 ns. This was shown by the stable RMSD along the MD trajectory.
Next, we compared MST2-PEPL with the MST2-SCR system, both from the best scoring
docking structures, to gain insight in the structural stability of both systems. We observed that
the RMSDs with respect to the initial structure (black) converge to the same values, between
5–7 Å, while with respect to the average structure (red) MST2-PEPL converges to a more stable
structure (2–3 Å), and MST2-SCR seems to drift towards RMSD of 4 Å. This may be indicative
of the decreased stability of the SCR peptide versus the PEPL. Furthermore, the highly struc-
tural stability of MST2-PEPA corroborates the experimental observation that the PEP but not
the SCR can disrupt RAF1-MST2 interaction by blocking the RAF1 interaction domain of the
MST2 SARAH domain.
Our simulations showed that the interaction betweenRASSF1A and PEPA dimer, the struc-
ture remains almost constant along the MD trajectorywith a slight variation at 170 ns due to
the fluctuation of the C-terminal part of the RASSF1A SARAH domain.
For RASSF1A-SCR dimer the picture was quite different, and RMSDave in respect to the
average structure keeps fluctuating (see Fig S7 in S1 File). This is due to the unfolding of the
scrambled peptide along the trajectory, which destabilizes this dimer (see Fig S8 in S1 File).
This is also revealed by the large SASA variation for the RASSF1A-SCR dimer, indicating that
PEP which was designed using the MST2 SARAH domain sequence could also bind to the
homolog sequence of RASSF1A SARAH domain, since both SARAH domain sequences have
31.4% identity and 64.6% similarity (Fig 2A).
Root mean square fluctuation (RMSF) values for all six dimer types were calculated in order
to gain insight into the flexibility of the SARAH domains upon complex formation (Fig 7). The
differences between aligned structures for PEPA and the scramble SCR one are notable. While
the aligned peptide, PEPA, is quite rigid along the trajectory, the SCR peptide shows more flexi-
bility and visits less stable conformations.
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In order to provide further insight in the relative stability of dimers containing PEP and
SCR peptides, we analyzed the interaction energy along their correspondingMD trajectories
(Fig 8 and Fig S10 in S1 File). Only the dimeric systems (MST2-PEPL, MST2-PEPA, and
MST2-SCR) and (RASSF1A-PEPA, and RASSF1-SCR) have the same overall sequence compo-
sition and thus can be compared exactly to each other, though the estimated energy corrections
for different residue composition are very small in this case for all systems.
In Fig S10 in S1 File is shown the total interaction energy (black) for the systems considered.
Clearly, the MST2-PEPA system presents the strongest interaction energy. Again, once the pep-
tide is alignedwith the MST2 SARAH domain, the structure is very stable. In the case of
MST2-SCR, the interaction energy drifts and decreases along the trajectory, showing a destabi-
lization of the dimer. Interestingly, a similar behavior is found in the RASSF1A-PEP complex,
in which this dimer is very stable. This further indicates that the peptide can also interact favor-
ably with the RASSF1A SARAH domain and hence can disrupt the MST2-RASSF1A dimeriza-
tion. Furthermore, the interaction energy distribution along the trajectory (see Fig S10 in S1
File) clearly shows that the MST2-SCR system presents a broad distribution profile with only a
small population at more negative energies. However, in the MST2-PEPA distribution a peak
of the energy values between -350 and -250 kcal/mol suggests a higher stability of the
MST2-PEPA system as compared to MST2-SCR. Similar relative interaction strengths have
been found for the RASSF1A-PEP and RASSF1A-SCR systems confirming the higher relative
stability of dimers containing PEP peptides.
Since the computational simulations suggest the existence of stable dimers betweenMST2
and the disruptor peptide, we decided to test it experimentally in order to validate our atomistic
models and prove the appropriateness of this approach for in silico testing of small molecules
Fig 7. Interactions of MST2 SARAH domains with designed peptides. Top: Structures of (A)
MST2-PEPS, (B) MST2-PEPL (blue-red), (C) MST2-PEPA and MST2-SCR dimers. Bottom: Structures of
(E) RASSF1A-PEPA, and (F) RASSF1A-SCR dimers. The color scale represents residue-level root mean
square fluctuations (RMSF) calculated for each dimer from MD data, with blue and red indicating rigid and
flexible amino acids, respectively.
doi:10.1371/journal.pcbi.1005051.g007
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Fig 8. Interaction energies of dimers including MST2 and RASSF1A SARAH domains and designed
peptides. Distributions of the total interaction energy between the two protomers for MST2-PEPS,
MST2-PEPL, MST2-PEPA, MST2-SCR, RASSF1A-PEPA and RASSF1-SCR dimers.
doi:10.1371/journal.pcbi.1005051.g008
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that target SARAH domain binding. The disruptor peptide was designed to include the mini-
mal binding interface betweenRAF1 and MST2 as mapped by peptides arrays, and we showed
that it disrupts this interaction very effectively [4]. In order to test our prediction that this pep-
tide could also disrupt the RASSF1A-MST2 dimer, we performed co-immunoprecipitation
experiments in MCF7 cells treated with the PEP or the SCR. Our experiments clearly demon-
strated that this peptide disrupts the MST2-RASSF1A dimerization (Fig 9A). Moreover, when
we tested the effects of this peptide on the MST2-MST2 interaction we also saw a disruption of
the MST2 homodimerization (Fig 9B) that could have important effects in the activation of the
kinase activity of this protein. All together, these experiments confirm the accuracy of our
atomistic models and validate the molecularmodeling and simulation methods used in this
work.
Discussion
SARAH domains are highly conserved throughout evolution and mediate the protein-protein
interaction between the MST1/2 kinases and members of the RASSF family. RASSF1A and
RASSF5 are key bona fide tumor suppressor genes, whose protein products have been shown
to regulate MST1/2 kinase activity [4, 37]. The effect of RASSF1A and RASSF5 over MST1/2
activation is mediated by heterodimerization through the SARAH domain of these proteins.
Thus, for a complete description of how RASSF1A and RASSF5 regulate MST2 we need to
understand first how the SARAH domains mediate the formation of these complexes [6]. Pre-
vious studies have focusedmainly on the RASSF5-MST2 dimer using crystal structures, NMR
spectroscopy and performing limited computational analysis based only on structureminimi-
zation rather than using extensive atomistic MD. This approach has significant limitations
since it does not allow the study of the dynamical behavior of protein dimers under realistic
conditions including explicit solvent molecules. In order to get a better understanding of the
structure of the SARAH dimers we used a combination of homologymodeling, docking,
Fig 9. Stear-MST2 disruptor peptide blocks MST2 interactions with (A) RASSF1A, and (B) with other MST2. (A)
MCF7 cells were co-transfected with Myc-tagged and Flag-tagged MST2. 48 h after transfection, cells were incubated
with 10 μM of N-terminal stearoylated peptides (stear-MST2 or stear-scrambled as control) for 1 h. The cells were lysed,
and MST2 was immunoprecipitated (IP) with antibody against the Flag-tag and Western blotted (WB) with anti-Myc tag
antibody in order to detect MST2 homodimers. The experiment was also repeated in a second way using an anti-Myc tag
antibody for IP and anti-Flag for Western blotting. (B) The cells lines indicated here were incubated with 10 μM of N-
terminal stearoylated peptides (stear-MST2 or stear-scrambled as control) for 1 h. The cells were lysed, and endogenous
MST2 was IP and WB for associated RASSF1A. As MCF7 cells do not express endogenous RASSF1A, they were
transfected with an HA-tagged RASSF1A expression vector.
doi:10.1371/journal.pcbi.1005051.g009
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molecularmodeling and atomistic molecular dynamics (MD) methods, to construct and study
a variety of models of MST2 homodimers, and of MST2-RASSF SARAH heterodimers, includ-
ing the important case of RASSF1A-MST2 dimers. In the first step, based on the high sequence
identity and similarity betweenRASSF1A and RASSF5, we used the MST2-RASSF5 dimer
structure (Fig 1) based on the available crystal structure (PDB ID: 4LGD) [13] as a template for
building new structuralmodels for the RASSF1A SARAH domain interacting with MST2, as
well as for MST2 homodimers. In the second step, to validate our models and also to search for
alternative solutions, we usedmolecular docking to generate a broad variety of dimeric homo
and heterodimer structures. Subsequently, we used atomistic MD simulations including
explicit water representation to test the stability of our dimer models that have been previously
ranked as best in the docking stage. With this approach, we showed that our models present a
significant stability when probed with atomistic MD simulations, justifying additional experi-
mental tests.
Importantly, in addition to the study of SARAH dimers we also simulated the structure of a
synthetic peptide that was purposely designed to be a strong MST2 binding partner, and was
used in our previous experiments. This peptide was designed to disrupt the RAF1-MST2
dimer, and to potentially activate MST2 kinase activity by binding to a short sequence of the
MST2 SARAH domain where RAF1 interacts with this protein. Interestingly, our new simula-
tions presented here show a different scenario for the effect of this peptide on the formation of
RASSF1A-MST2 and MST2-MST2 dimers. Essentially, our new simulations indicate that the
peptide would also prevent the formation of the RASSF1A-MST2 dimers, in addition to inhib-
iting the formation of MST2 homodimers. Importantly, we have validated experimentally
these predictions of our in silico results, indicating strongly that we have correctly characterized
the structure of the SARAH domain dimers, and confirming the relevance of our approach to
the study of the structure of SARAH domains in particular, and of other protein-protein inter-
actions in general. The molecular interactionmechanisms revealed here also shed new light on
how RASSF1A regulates the MST2 kinase activity via dimer formation.
Significantly, our specific findings regarding SARAH domain interactions, together with the
general methods used in this work, can help to designmore effective strategies to target human
cancer tumors (e.g., by deregulation of their RASSF1A/MST2 signaling networks). We also
hope that this study is a first step towards integrating atomistic-level mechanistic information
about the structures and conformational dynamics of proteins interacting through SARAH
domains, with information available on their system-level functions in cellular signaling.
Methods
Experimental methods
Cell lines and transfections. MCF7, HeLa and HCC1937 where grown in Dulbecco's
Modified Eagle's medium (DMEM) supplemented with 10% foetal calf serum (Gibco-BRL)
and 2mM L-glutamine. MCF7 cells were transfected using Lipofectamine following the manu-
facturer’s instructions.
Immunoprecipitation and immunoblotting. Cells were lysed as previously described [1]
48 hours after transfection. Lysates were incubated with the different antibodies for 4h at 4°C.
Immunoprecipitates were washed and resolved by SDS-PAGE as previously described [17].
Disruptor peptides. The peptides used in this study for affecting the dimer stability (see
Fig 2D) were synthesized by the Cancer Research UK peptide Synthesis Laboratory and have
been characterized recently [4].
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Homology modeling and docking
The initial structure of an MST2-RASSF5 SARAH domain dimer was constructed based on the
crystal structure PDB ID: 4LGD, chain C and G for MST2 and RASSF5, respectively [13].
To our knowledge, there is no crystal structure of RASSF1A. Therefore we have used the
sequence that is available from SwissProt [38] (Uniprot Q9NS23). Searches for homologous
protein were carried out using UniProt [39] and the RCSB PDB data banks. The Clustal
Omega program [15–17] was used for sequence alignment. A homologymodel of the
RASSF1A SARAH domain was built using the comparative modeling environment, SWISS--
MODEL [40–43]. The PDB structure 4LGD (chain G) for the RASSF5 SARAH domain was
used as a template. In order to get an optimal packing structure betweenRASSF1A and MST2
SARAH domains, a docking study was carried out, which used the most probable structures (i.
e, with the highest scoring function) generated by the Zdock server [19–21].
All-atom validation of docking structures and refinement using MD
Four systems were prepared for atomistic MD simulations: one based on the crystal structure
for the MST2-RASSF5 SARAH domain dimer, one with homologymodel structures for the
MST2-RASSF1A SARAH domain dimer, one corresponding to the homodimerMST2-MST2
using the MST2 protomer structure from crystal structure and docking another copy of the
MST2 protomer, and finally one with a homologymodel for the designed disrupting peptide.
Each system was solvated with explicit TIP3P water molecules [44] prior to minimization,
heating and equilibration. The total number of atoms for each system including water mole-
cules is reported in Table 1.
MD simulations were performed using the NAMD software [45] with the CHARMM36
force field [46]. All the atomistic MD simulations were performed in the NPT ensemble (i.e.
constant number of atoms, pressure and temperature), using periodic boundary conditions, as
in our similar recent MD studies [47–49]. We used the modifiedNosé-Hoover Langevin piston
method implemented in NAMD [50, 51] with damping time of 0.1 ps, whilemaintaining a pres-
sure of 1.01325 bar. The temperature was set to 310 K and controlled using a Langevin thermo-
stat with a 1 ps-1 damping coefficient. Ions were added using the automatic script provided in
VMD [35] to achieve a neutral pH. The Particle Mesh Ewald methodwas used to include elec-
trostatic effects [52]. The switching distance for non-bonded electrostatic and van derWaals
interactions was 9.5 Å with a cut-off distance of 12 Å. The integration time step was 1 fs.
A summary of the simulations performed and analyzed here is given in Table 1. To address
convergence, errors were estimated by block averaging and all the MD simulations were per-
formed at least twice longer than needed to obtain the average values reported in each case. In
addition, the PMF profiles presented in Figs S14 and S15 in S1 File were calculated and pre-
sented for different trajectory segments (e.g., the first, second and last third of each trajectory
shown in Fig S14B, S14C, and S14D in S1 File, respectively, and the first and second half of
each corresponding trajectory of Fig S15B and S15C in S1 File), as well as for the entire trajec-
tory data (see Fig S14A and S14B in S1 File).
Supporting Information
S1 File. Supplemental data showing Figures S1 to S15 and the corresponding legends and
references.
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